|
Volumn 89, Issue 4, 2001, Pages 158-170
|
Pathology and pathophysiology of drug-induced arterial injury in laboratory animals and its implications on the evaluation of novel chemical entities for human clinical trials
|
Author keywords
[No Author keywords available]
|
Indexed keywords
3 AMINOPROPIONITRILE;
ADRENALIN;
ALLYLAMINE;
ANOREXIGENIC AGENT;
BETA ADRENERGIC RECEPTOR STIMULATING AGENT;
DIGOXIN;
DOPAMINE RECEPTOR STIMULATING AGENT;
ENDOTHELIN 1;
ENDOTHELIN RECEPTOR AGONIST;
INOTROPIC AGENT;
MITOMYCIN;
MONOCROTALINE PYRROLE;
NORADRENALIN;
PHOSPHODIESTERASE INHIBITOR;
VASOACTIVE AGENT;
VASOCONSTRICTOR AGENT;
VASODILATOR AGENT;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ARTERY INJURY;
CARDIOVASCULAR FUNCTION;
CORRELATION FUNCTION;
DOG;
DRUG MECHANISM;
GENE EXPRESSION;
NONHUMAN;
PATHOGENESIS;
PATHOPHYSIOLOGY;
PRIORITY JOURNAL;
RISK ASSESSMENT;
SHORT SURVEY;
TOXICITY TESTING;
ANIMALIA;
CANIS FAMILIARIS;
|
EID: 0035165794
PISSN: 09019928
EISSN: None
Source Type: Journal
DOI: 10.1111/j.0901-9928.2001.890404.x Document Type: Short Survey |
Times cited : (34)
|
References (7)
|